PAUSE: Psychotherapeutic Augmentation of Brain Stimulation Effects
Study Details
Study Description
Brief Summary
This study aims to investigate effectiveness and feasability of a 15-week group psychotherapeutic intervention as continuation treatment after electroconvulsive therapy in severely depressed patients. Feasibility and acceptance of the half-open manualized CBT intervention are assessed. Depressive symptoms, quality of life and emotion regulation skills will be assessed before ECT treatment, before and after the 15-week group CBT intervention and at a 6 months follow-up after treatment end and compared to depressed patients treated with ECT who did not partake in group CBT. Moreover, patients will attend two indidivual pre-group sessions with one of the group therapist and one individual post-group session
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
While Electroconvulsive therapy (ECT) is a highly effective anti-depressant treatment, a relevant number of patients experience recurrence of depressive episodes within 6 months.
One previous study suggested that ECT treatment effects can be effectively sustained by group CBT (Cognitive Behavioral Therapy, Brakemeier et a. 2014). This previous implementation used a closed CBT-group set-up that implicated a longer waiting period for patients after finishing the acute ECT and did not investigate whether patients who did not respond to ECT could sufficiently profit from group CBT. In order to suit the complex needs of patients in a natural clinical setting, the present study aims to investigate the feasibility and effectiveness of a half-open continuous group CBT (named EffECtive 2.0) as continuation treatment for all ECT patients regardless of remission status after ECT.
This prospective study will recruit a total of 30 patients who concluded treatment with right-unilateral ultra-brief ECT for depression. Patients self-allocate to the group that is offered in addition to continuation treatment as usual (TAU, e.g. pharmacological treatment, continuation ECT, individual psychotherapy). ECT completers who choose not to partake in the group for practical concerns or lack of interest and receive treatment as usual are recruited as a control group.
The primary outcome measure is the change depression severity, measured with the Montgomery-Åsberg Depression Rating Scale (MADRS). Secondary outcomes are quality of life assessed with the short-version of the WHO quality of life questionnaire (WHOQOL-Bref) and emotion regulation as assessed with cognitive emotion regulation questionnaire (CERQ). These measures will be assessed before, during, immediately after acute ECT and six and 12 months into continuation therapy.
It is hypothesized that a group CBT as add-on treatment to TAU will lead to more favorable outcomes concerning depression severity, quality of life and emotion regulation.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Group CBT 15-week group CBT with a focus on improvement of social interactions by cognitive re-modelling and role plays. Patients may simultaneously receive continuation ECT and/or individual psychotherapy and/or take anti-depressive medication. |
Behavioral: EffEKTiv 2.0 group CBT as continuation treatment after ECT in depressed patients
Group CBT with a maximum number of 8 participants. Group is half-open allowing a starting date right after completion of acute ECT treatment. Patients participate for 15 sessions, which are framed by 2 individual sessions before joining the group and one individual session at treatment end.
Other: Treatment as usual
Can include continuation ECT, psychopharmacological treatment, individual psychotherapy
|
| Experimental: Treatment as Usual Patients may receive continuation ECT and/or individual psychotherapy and/or take anti-depressive medication. |
Other: Treatment as usual
Can include continuation ECT, psychopharmacological treatment, individual psychotherapy
|
Outcome Measures
Primary Outcome Measures
- Clinican-Rated Depressive Symptoms at treatment end [End of group therapy treatment (~6 months after ECT treatment)]
MADRS
- Clinican-Rated Depressive Symptoms at follow-up [6 months after end of group therapy]
MADRS
Secondary Outcome Measures
- Quality of life at follow-up [6 months after end of group therapy]
WHOQL-Bref
- Emotion regulation capacities at follow-up [6 months after end of group therapy]
Cognitive Emotion Regulation Questionnaire
- Self-Reported Depressive Symptoms at treatment end [End of group therapy treatment (~6 months after ECT treatment)]
BDI
- Self-Reported Depressive Symptoms at follow up [6 months after end of group therapy]
BDI
Eligibility Criteria
Criteria
Inclusion Criteria:
- treated with ECT for major depression
Exclusion Criteria:
-
severe comorbid personality disorders
-
principal diagnosis other than depression
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Charité | Berlin | Germany | 12203 |
Sponsors and Collaborators
- Charite University, Berlin, Germany
Investigators
- Principal Investigator: Simone Grimm, Prof. Dr., Charite Universitaetsmedizin
Study Documents (Full-Text)
None provided.More Information
Publications
- PAUSE